Observation Study on Reducing the Risk of Liver Cancer Associated With Hepatitis B (Zhiyuan) Project.

NCT07169656 · clinicaltrials.gov ↗

RECRUITING

Status

15000

Enrollment

OTHER

Sponsor class

Conditions

Chronic Hepatitis b

Interventions

DRUG: ETV,TDF,TAF,TMF
DRUG: Peginterferon α-2b injection

Sponsor

The First Affiliated Hospital of Zhengzhou University